We are live on ! Find out more
MCP

Mirador Capital Partners Portfolio holdings

AUM $817M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+17.91%
1 Year Est. Return
+42.46%
3 Year Est. Return
+102.43%
5 Year Est. Return
+126.93%
10 Year Est. Return
+392.96%
AUM
$268M
AUM Growth
+$28.2M
Cap. Flow
+$13.8M
Cap. Flow %
5.15%
Top 10 Hldgs %
33.6%
Holding
154
New
17
Increased
85
Reduced
34
Closed
2

Sector Composition

Rank Sector Weight
1 Technology 19.52%
2 Healthcare 12.43%
3 Financials 9.71%
4 Communication Services 9.69%
5 Consumer Discretionary 6.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UN
26
DELISTED
Unilever NV New York Registry Shares
UN
$3.05M 1.14%
57,239
+777
+1% +$39.5K
WORK
27
DELISTED
Slack Technologies, Inc.
WORK
$3.04M 1.14%
97,735
+84,946
+664% +$2.55M
TRHC
28
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$3.02M 1.13%
55,184
+4,053
+8% +$232K
DIS icon
29
Walt Disney
DIS
$181B
$2.95M 1.1%
26,459
+1,471
+6% +$162K
DEO icon
30
Diageo
DEO
$53.6B
$2.86M 1.07%
21,291
+277
+1% +$38K
IAU icon
31
iShares Gold Trust
IAU
$64.4B
$2.65M 0.99%
77,895
+2,242
+3% +$73.5K
BMY icon
32
Bristol-Myers Squibb
BMY
$132B
$2.54M 0.95%
43,214
+480
+1% +$28.7K
INTU icon
33
Intuit
INTU
$89B
$2.54M 0.95%
8,561
KKR icon
34
KKR & Co
KKR
$92.3B
$2.48M 0.93%
80,403
+637
+0.8% +$17.1K
DHR icon
35
Danaher
DHR
$144B
$2.43M 0.91%
15,489
+190
+1% +$27.3K
UNH icon
36
UnitedHealth
UNH
$370B
$2.35M 0.88%
7,982
+158
+2% +$45.3K
GILD icon
37
Gilead Sciences
GILD
$165B
$2.33M 0.87%
30,333
+502
+2% +$38.5K
MRK icon
38
Merck
MRK
$318B
$2.27M 0.85%
30,787
+469
+2% +$35.3K
CYTK icon
39
Cytokinetics
CYTK
$10.4B
$2.27M 0.85%
96,107
-1,247
-1% -$23.4K
BLK icon
40
Blackrock
BLK
$176B
$2.21M 0.82%
4,055
+39
+1% +$19.7K
CSCO icon
41
Cisco
CSCO
$479B
$2.15M 0.8%
46,156
+953
+2% +$41.8K
CRM icon
42
Salesforce
CRM
$158B
$2.14M 0.8%
11,430
+42
+0.4% +$7.08K
BSJL
43
DELISTED
Invesco BulletShares 2021 High Yield Corporate Bond ETF
BSJL
$2.1M 0.78%
92,509
-270,694
-75% -$6.11M
BSCO
44
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$2.06M 0.77%
93,385
-7,317
-7% -$158K
SAP icon
45
SAP
SAP
$238B
$2.05M 0.77%
14,660
+67
+0.5% +$8.26K
PFE icon
46
Pfizer
PFE
$153B
$1.97M 0.74%
63,396
+8,094
+15% +$275K
ARCC icon
47
Ares Capital
ARCC
$14.4B
$1.81M 0.68%
125,391
-1,400
-1% -$18.9K
T icon
48
AT&T
T
$163B
$1.8M 0.67%
78,683
+640
+0.8% +$14.6K
KO icon
49
Coca-Cola
KO
$375B
$1.72M 0.64%
+38,498
New +$1.77M
EXTR icon
50
Extreme Networks
EXTR
$3.15B
$1.69M 0.63%
388,417
+44,492
+13% +$157K

Similar funds

Mirador Capital Partners's Q2 2020 Portfolio in Review

As of Q2 2020, Mirador Capital Partners held 154 positions worth $268M, up 12% from $239M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Mirador Capital Partners deployed $13.8M of net new capital in Q2 2020, opening 17 new positions and adding to 85 existing holdings. Its largest new stake was SPDR Gold Trust: 20,310 shares worth $3.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Invesco BulletShares 2021 High Yield Corporate Bond ETF, an estimated $6.11M trimmed.

  • Mirador Capital Partners's largest Q2 2020 buy was SPDR Gold Trust: 20,310 shares worth $3.4M.
  • Mirador Capital Partners added most to Invesco BulletShares 2020 Corporate Bond ETF in Q2 2020, an estimated $6.72M increase.
  • Mirador Capital Partners's biggest Q2 2020 reduction was Invesco BulletShares 2021 High Yield Corporate Bond ETF, cutting an estimated $6.11M.
  • Mirador Capital Partners fully exited Lazard in Q2 2020, selling an estimated $667K.
  • Mirador Capital Partners's ten largest holdings make up 34% of its $268M portfolio in Q2 2020.
  • Mirador Capital Partners opened 17 new positions and closed 2 in Q2 2020.
  • Mirador Capital Partners's portfolio value rose 12% quarter-over-quarter to $268M.

Based on Mirador Capital Partners's 13F filing for Q2 2020, filed 6 Aug 2020.